REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Lenalidomide
Related studies linked through entity extraction aliases.
Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)
- Status
- COMPLETED
- Phase
- PHASE2
Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1
- Status
- TERMINATED
- Phase
- PHASE2
Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality
- Status
- COMPLETED
- Phase
- PHASE2